Premium
Chronic fentanyl application induces adrenocortical insufficiency
Author(s) -
OLTMANNS K. M.,
FEHM H. L.,
PETERS A.
Publication year - 2005
Publication title -
journal of internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.625
H-Index - 160
eISSN - 1365-2796
pISSN - 0954-6820
DOI - 10.1111/j.1365-2796.2005.01483.x
Subject(s) - medicine , opiate , hydrocortisone , adrenal insufficiency , fentanyl , anesthesia , adrenocortical insufficiency , stressor , transdermal , endocrinology , pharmacology , psychiatry , receptor
. We report a case of a 64‐year‐old man with secondary adrenocortical insufficiency who has been on a chronic transdermal fentanyl treatment because of sciatic pain syndrome. Shortly before admission to our hospital, the patient had discontinued his hydrocortisone medication. Adrenal crisis was assumed and during therapy with hydrocortisone infusion, the patient recovered. We suspected an opiate‐induced suppression of the hypothalamus‐pituitary‐adrenal (HPA) axis. Therefore, we gradually reduced the opiate dosage. After 1 week, HPA axis function was markedly improved. We conclude that opiate medication may inhibit – in a life‐threatening way – the organism's ability to respond to physical, emotional or metabolic stressors.